Understanding PFAS in Pharmaceutical Manufacturing
LCMSArticle | Product

Understanding PFAS in Pharmaceutical Manufacturing

PFAS play vital roles in pharma but pose risks as “forever chemicals.” Thermo Fisher’s LC-MS solution enables precise PFAS screening in packaging and processes, ensuring compliance and safety.
Understanding PFAS in Pharmaceutical Manufacturing
Collision-Based Ion-activation and Dissociation
LCMSArticle | Academy

Collision-Based Ion-activation and Dissociation

Collision-based ion activation, developed nearly 80 years ago, remains the most widely used fragmentation method. Learn about three key techniques on Thermo Scientific MS.
Collision-Based Ion-activation and Dissociation
Inside Laboratoire Anti-Dopage Français (LADF): An Interview with Director Dr. Magnus Ericsson
GCMSLCMSArticle | Product

Inside Laboratoire Anti-Dopage Français (LADF): An Interview with Director Dr. Magnus Ericsson

At the forefront of anti-doping science, LADF under Dr. Magnus Ericsson leverages Thermo Fisher technologies to detect banned substances and ensure fair play.
Inside Laboratoire Anti-Dopage Français (LADF): An Interview with Director Dr. Magnus Ericsson
Understanding Nitrosamine Drug Substance-Related Impurities (NDSRIs)
GCMSLCMSArticle | Health

Understanding Nitrosamine Drug Substance-Related Impurities (NDSRIs)

Nitrosamine drug substance-related impurities (NDSRIs) pose major risks in pharmaceuticals. Learn about their sources, regulations, and detection methods for drug safety.
Understanding Nitrosamine Drug Substance-Related Impurities (NDSRIs)
NDMA in macrolides: GC-MS/MS method for its detection and study of its formation
GCMSLCMSScientific article | Science and research

NDMA in macrolides: GC-MS/MS method for its detection and study of its formation

This study evaluates the risk of NDMA formation from macrolide antibiotics, highlighting solubility-related analytical challenges and the role of drug form and storage in NDMA levels.
NDMA in macrolides: GC-MS/MS method for its detection and study of its formation
Mucinomics: The Next Frontier of Mass Spectrometry
LCMSArticle | Science and research

Mucinomics: The Next Frontier of Mass Spectrometry

Dr. Stacy Malaker shared advances in mucin characterization, enrichment, and their role in disease research during a Nature webinar. Here are the key takeaways.
Mucinomics: The Next Frontier of Mass Spectrometry
LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplements
LCMSScientific article | Science and research

LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplements

Assess authenticity and detect adulteration in Tribulus terrestris supplements using untargeted LC-HRMS metabolomics combined with chemometric and AI tools.
LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplements
Live from the Lab: Solutions for Omics Research - Dr Thomas Moehring & Dr Hamish Stewart
LCMSArticle | Events

Live from the Lab: Solutions for Omics Research - Dr Thomas Moehring & Dr Hamish Stewart

Join us on June 12th for the 3rd edition of Live from the Lab! This hybrid event will showcase the latest advancements in mass spectrometry technology.
Live from the Lab: Solutions for Omics Research - Dr Thomas Moehring & Dr Hamish Stewart
Imaging Large Multiprotein Complexes Using Native Nano DESI Mass Spectrometry
LCMSArticle | Science and research

Imaging Large Multiprotein Complexes Using Native Nano DESI Mass Spectrometry

Prof. Helen Cooper from the University of Birmingham shared new insights into imaging large multiprotein complexes using native nano-DESI mass spectrometry.
Imaging Large Multiprotein Complexes Using Native Nano DESI Mass Spectrometry
News from LabRulezLCMS Library - Week 16, 2025
LCMSArticle | Application

News from LabRulezLCMS Library - Week 16, 2025

This week we bring you application notes by Agilent Technologies, Knauer, Shimadzu, Thermo Fisher Scientific and Waters Corporation!
News from LabRulezLCMS Library - Week 16, 2025